139 related articles for article (PubMed ID: 8882594)
1. Vasorelaxant properties of norbormide, a selective vasoconstrictor agent for the rat microvasculature.
Bova S; Trevisi L; Debetto P; Cima L; Furnari M; Luciani S; Padrini R; Cargnelli G
Br J Pharmacol; 1996 Mar; 117(6):1041-6. PubMed ID: 8882594
[TBL] [Abstract][Full Text] [Related]
2. Norbormide: a calcium entry blocker with selective vasoconstrictor activity in rat peripheral arteries.
Bova S; Cima L; Golovina V; Luciani S; Cargnelli G
Cardiovasc Drug Rev; 2001; 19(3):226-33. PubMed ID: 11607040
[TBL] [Abstract][Full Text] [Related]
3. Distribution of the vasoconstrictor and vasorelaxant effects of norbormide along the vascular tree of the rat.
Cavalli M; Omiciuolo L; Cargnelli G; Cima L; Hopkins B; Bova S
Life Sci; 2004 Sep; 75(18):2157-65. PubMed ID: 15325842
[TBL] [Abstract][Full Text] [Related]
4. Signaling mechanisms for the selective vasoconstrictor effect of norbormide on the rat small arteries.
Bova S; Trevisi L; Cima L; Luciani S; Golovina V; Cargnelli G
J Pharmacol Exp Ther; 2001 Feb; 296(2):458-63. PubMed ID: 11160631
[TBL] [Abstract][Full Text] [Related]
5. Ca(2+) entry blocking and contractility promoting actions of norbormide in single rat caudal artery myocytes.
Fusi F; Saponara S; Sgaragli G; Cargnelli G; Bova S
Br J Pharmacol; 2002 Oct; 137(3):323-8. PubMed ID: 12237251
[TBL] [Abstract][Full Text] [Related]
6. Relaxant and Ca2+ channel blocking properties of norbormide on rat non-vascular smooth muscles.
Bova S; Cavalli M; Cima L; Luciani S; Saponara S; Sgaragli G; Cargnelli G; Fusi F
Eur J Pharmacol; 2003 Jun; 470(3):185-91. PubMed ID: 12798957
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms of the vasorelaxant effect of 1, 5-dihydroxy-2, 3-dimethoxy-xanthone, an active metabolite of 1-hydroxy-2, 3, 5-trimethoxy-xanthone isolated from a Tibetan herb, Halenia elliptica, on rat coronary artery.
Wang Y; Shi JG; Wang MZ; Che CT; Yeung JH
Life Sci; 2008 Jan; 82(1-2):91-8. PubMed ID: 18045622
[TBL] [Abstract][Full Text] [Related]
8. Effects of the calcium channel facilitator, CGP 28,392, on different modes of contraction in smooth muscle of rabbit and rat aortae and guinea-pig taenia caeci.
Karaki H; Nagase H; Ozaki H; Urakawa N; Weiss GB
Br J Pharmacol; 1986 Oct; 89(2):423-9. PubMed ID: 3779218
[TBL] [Abstract][Full Text] [Related]
9. Vascular effects of Siberian ginseng (Eleutherococcus senticosus): endothelium-dependent NO- and EDHF-mediated relaxation depending on vessel size.
Kwan CY; Zhang WB; Sim SM; Deyama T; Nishibe S
Naunyn Schmiedebergs Arch Pharmacol; 2004 May; 369(5):473-80. PubMed ID: 15095033
[TBL] [Abstract][Full Text] [Related]
10. Calcium-antagonist effects of norbormide on isolated perfused heart and cardiac myocytes of guinea-pig: a comparison with verapamil.
Bova S; Cargnelli G; D'Amato E; Forti S; Yang Q; Trevisi L; Debetto P; Cima L; Luciani S; Padrini R
Br J Pharmacol; 1997 Jan; 120(1):19-24. PubMed ID: 9117093
[TBL] [Abstract][Full Text] [Related]
11. Structurally novel antihypertensive compound, McN-5691, is a calcium channel blocker in vascular smooth muscle.
Flaim SF; Gleason MM; Hedberg A; Shank RP; McCullough JR; Gill A; Damiano BP; Brannan MD; Carson JR
J Pharmacol Exp Ther; 1991 Jan; 256(1):279-88. PubMed ID: 1846419
[TBL] [Abstract][Full Text] [Related]
12. The Selective Rat Toxicant Norbormide Blocks K
Saponara S; Fusi F; Spiga O; Trezza A; Hopkins B; Brimble MA; Rennison D; Bova S
Front Pharmacol; 2019; 10():598. PubMed ID: 31191321
[TBL] [Abstract][Full Text] [Related]
13. Species differences in the effects of an endogenous inotropic factor (EIF) on the myocardium and aortic smooth muscle.
Paskvalin M; Khatter JC
Life Sci; 1997; 61(14):1361-9. PubMed ID: 9335225
[TBL] [Abstract][Full Text] [Related]
14. In vitro relaxation of vascular smooth muscle by atropine: involvement of K+ channels and endothelium.
Kwan CY; Zhang WB; Kwan TK; Sakai Y
Naunyn Schmiedebergs Arch Pharmacol; 2003 Jul; 368(1):1-9. PubMed ID: 12802579
[TBL] [Abstract][Full Text] [Related]
15. Effects of 8-bromoguanosine 3':5'-cyclic monophosphate on phenylephrine-induced phosphatidylinositol hydrolysis and contraction in rat caudal artery.
Lum Min SA; Tabrizchi R
Br J Pharmacol; 1995 Sep; 116(1):1697-703. PubMed ID: 8564240
[TBL] [Abstract][Full Text] [Related]
16. Mechanism of endothelin-induced contraction in guinea-pig trachea: comparison with rat aorta.
Hay DW
Br J Pharmacol; 1990 Jun; 100(2):383-92. PubMed ID: 1696155
[TBL] [Abstract][Full Text] [Related]
17. Regulation of cell calcium and contractility in mammalian arterial smooth muscle: the role of sodium-calcium exchange.
Ashida T; Blaustein MP
J Physiol; 1987 Nov; 392():617-35. PubMed ID: 2451733
[TBL] [Abstract][Full Text] [Related]
18. Effects of estradiol on phenylephrine contractility associated with intracellular calcium release in rat aorta.
Castillo C; Ceballos G; Rodríguez D; Villanueva C; Medina R; López J; Méndez E; Castillo EF
Am J Physiol Cell Physiol; 2006 Dec; 291(6):C1388-94. PubMed ID: 16885392
[TBL] [Abstract][Full Text] [Related]
19. Voltage- and time-dependent inhibitory effects on rat aortic and porcine coronary artery contraction induced by propafenone and quinidine.
Pérez-Vizcaíno F; Fernández del Pozo B; Zaragozá F; Tamargo J
Br J Pharmacol; 1994 Dec; 113(4):1281-8. PubMed ID: 7889284
[TBL] [Abstract][Full Text] [Related]
20. Rho-dependent kinase is involved in agonist-activated calcium entry in rat arteries.
Ghisdal P; Vandenberg G; Morel N
J Physiol; 2003 Sep; 551(Pt 3):855-67. PubMed ID: 12853654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
